Early recurrence risk: aromatase inhibitors versus tamoxifen.
about
Early recurrence risk: aromatase inhibitors versus tamoxifen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early recurrence risk: aromatase inhibitors versus tamoxifen.
@en
Early recurrence risk: aromatase inhibitors versus tamoxifen.
@nl
type
label
Early recurrence risk: aromatase inhibitors versus tamoxifen.
@en
Early recurrence risk: aromatase inhibitors versus tamoxifen.
@nl
prefLabel
Early recurrence risk: aromatase inhibitors versus tamoxifen.
@en
Early recurrence risk: aromatase inhibitors versus tamoxifen.
@nl
P2093
P2860
P356
P1476
Early recurrence risk: aromatase inhibitors versus tamoxifen
@en
P2093
Federica Cuppone
Francesco Cognetti
Michele Milella
Paolo Carlini
Vanja Vaccaro
P2860
P304
P356
10.1586/ERA.10.54
P50
P577
2010-08-01T00:00:00Z